Synthesis of an Unnatural Phospholipid for use in Pulmonary Surfactant Therapy
Neonatal respiratory distress syndrome (RDS) is a disease that affects premature infants born prior to 32 weeks gestation. The main cause is a deficiency in pulmonary surfactant due to immature type II pneumocyte cells found in the alveoli. These cells are not capable of producing the required surfa...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
2012
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10214/3549 |